Omron Healthcare India Collaborates with AliveCor India

Overview

Omron Healthcare India, the Indian arm of the Japanese global leader in medical equipment for home health monitoring and treatment, has announced its collaboration with AliveCor India, the Indian subsidiary of the global leader in FDA-cleared, CE marked and CDSCO approved personal electrocardiogram (ECG) technology.

With this partnership, Omron Healthcare India now offers AI-based handheld ECG technology besides being a top blood pressure monitor player in India.

Post Collaboration

• This collaboration, marking a significant milestone in Omron’s ""Going for Zero"" vision to enhance cardiovascular health awareness and prevent incidents, brings forth devices including the first home BPM+ECG Monitoring FDA cleared Device (blood pressure monitor with AliveCor ECG capability in a single device) for early CVD (cardiovascular disease) detection and management and AliveCor's FDA-cleared world’s most clinically-validated and pocket-sized personal ECGs. 
• These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more.

Omron Healthcare

• Omron Healthcare has been at the forefront of hypertension management for almost half a century, pioneering innovative solutions to tackle this silent threat. 
• However, as time has advanced, Omron has come to realize the necessity of expanding its scope beyond hypertension. 
• With a deeper dive into cardiovascular health, the company has unearthed the crucial role of Afib as a significant contributor to stroke and cardiovascular disease risk. 
• Furthermore, hypertension is one of the leading risk factors for the development of AFib.

Stroke

• Afib disrupts the normal heartbeat and causes small & irregular vibrations in the heart, leading to the collection of blood inside. 
• This can create a clot in the heart, which can travel to the brain, and cause a stroke.

Words from Omron Healthcare India
“Stroke risk is 3.4 times higher with hypertension, but it is 5 times higher with Afib and so if people frequently have Afib, they may face a stroke shortly. This signifies that monitoring both ECG and blood pressure at home and keeping the doctor informed is crucial for the early management of cardiovascular and cerebrovascular health conditions like stroke,” says Tetsuya Yamada, managing director, Omron Healthcare India.

On Collaboration

• Elaborating on the collaboration with AliveCor, Tetsuya Yamada further added, “Guided by our vision – ""Going for Zero,"" to eliminate cardiovascular and cerebrovascular disease episodes, we are collaborating with like-minded organizations such as AliveCor to provide new technologies that enhance accuracy, quality, and accessibility of home as well as remote patient monitoring, empowering individuals to manage their conditions effectively. 
• The collaboration will also help to answer one of the underlying social issues which are the limited number of cardiologists in the country. 
• With these innovative devices, we can cut down on the waiting period for ECG measurement and also enhance accessibility which will help the patients keep their doctors and caregivers informed in a convenient and real-time manner to make them make more informed and better decision-making for cardiovascular health management.""

Words from AliveCor

Anuj Seth, managing director, AliveCor India said on the occasion, “At AliveCor, delivering cutting-edge technology that revolutionizes cardiac care through mobile technology is ingrained in our ethos. We are dedicated to expanding access to remote patient care to reach as many individuals as possible. Partnering with Omron Healthcare India allows us to extend the reach of our products to more patients, thereby saving more lives.”

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!